Yale and Alexion report advance in spinal cord repair

NAGOYA, JAPAN, Oct. 25, 1999 -- Researchers from the Yale University School of Medicine and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported that transplanting genetically modified pig cells into surgically damaged spinal cords of non-human primates can regenerate the myelin sheath around the injured fragment of the spinal cord. Alexion believes that these results represent a critical milestone in progressing its spinal cord product into patient trials.

The report, entitled "Xenotransplantation of Transgenic Pig Myelin Forming Cells Promotes Axonal Regeneration and Restores Conduction Across the Transected Spinal Cord," is based on research conducted in the laboratories of Dr. Jeffrey D. Kocsis of the Department of Neurology, Yale University School of Medicine, and Dr. William L. Fodor, Senior Director of Xenotransplantation at Alexion Pharmaceuticals, Inc. and their colleagues.

"This promising data demonstrates that immunoprotected transgenic pig cells can survive and regenerate myelin sheaths around damaged neurons within the spinal cords of non-human primates," said Stephen Squinto, Senior Vice President and Chief Technology Officer of Alexion. "Together with our findings also presented today which showed that these transgenic pig cells both engraft and restore electrical conductance in rodent models of spinal injury, these data suggest that this approach may lead to the development of a new therapy for spinal cord injury patients."

Specific antibody binding to the surface of a foreign cell initiates a process called the "complement" cascade, which results in the destruction of the foreign cell. Complement-mediated rejection of nerve cell xenografts presents a major obstacle to effectively replacing damaged cells in the central nervous system. Alexion scientists address this problem in two ways. First, they produce pig cells that reduce or eliminate the expression of certain pig sugars which are targeted by the triggering antibod

Contact: Tom Baker
212-696-4455 Ext 205
Noonan/Russo Communications

Page: 1 2 3

Related biology news :

1. Alexion and Yale discover harmful complement activation in patients with acute coronary syndrome
2. Harvard and Alexion researchers report successful transplantation of immuneprotected neurons in primate model of Parkinsons disease
3. March of Dimes statement on newborn screening report
4. Researchers report new gene test for isolated cleft lip and palate
5. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
6. Unicellular organisms contribute more nitrogen to ocean that reported earlier
7. Researchers report new gene test for isolated cleft lip and palate
8. British scientists exclude maverick colleagues, says report
9. New public policy & aging report highlights facts and fiction about anti-aging medicine
10. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere
11. Researchers report major advance in gene therapy technique

Post Your Comments:

(Date:8/6/2019)... ... August 06, 2019 , ... ... concerns. One plant-based food in particular quickly entered the limelight – meat alternatives. ... use a thermogelling and emulsifying ingredient such as methyl cellulose. This ingredient is ...
(Date:8/1/2019)... , ... August 01, 2019 , ... The GENSPEED platform ... of care. It is fully developed with over 100 units deployed in the ... new fields of use, our collaboration with axiVEND will give us a foothold in ...
(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... July 25, 2019 , ... ... collaboration and dialogue, today announces its Boston BD conference to be ... of Biotech Week Boston , the event provides an opportunity for attendees ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma ... Biotech. The film focuses on regenerative veterinary medicine as a means of improving ... recently included in the Brentwood and Pacific Palisades International Film Festival in Los ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... network with the appointment of Biofeedback Tech Ltd as its authorised ... an essential part of many therapeutic treatments and clinical assessment protocols to treat ...
Breaking Biology Technology:
Cached News: